HOOKIPA Pharma Statistics

Total Valuation

HOOKIPA Pharma has a market cap or net worth of $18.00 million. The enterprise value is -$20.92 million.

Market Cap	18.00M
Enterprise Value	-20.92M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

HOOKIPA Pharma has 12.67 million shares outstanding. The number of shares has increased by 16.01% in one year.

Current Share Class	9.79M
Shares Outstanding	12.67M
Shares Change (YoY)	+16.01%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	21.45%
Float	9.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.98
Forward PS	n/a
PB Ratio	0.55
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.02.

Current Ratio	3.61
Quick Ratio	2.92
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -105.79% and return on invested capital (ROIC) is -64.45%.

Return on Equity (ROE)	-105.79%
Return on Assets (ROA)	-45.20%
Return on Invested Capital (ROIC)	-64.45%
Return on Capital Employed (ROCE)	-167.87%
Revenue Per Employee	$107,483
Profits Per Employee	-$842,678
Employee Count	87
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	-106,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.45% in the last 52 weeks. The beta is 0.95, so HOOKIPA Pharma's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-82.45%
50-Day Moving Average	1.22
200-Day Moving Average	2.40
Relative Strength Index (RSI)	47.39
Average Volume (20 Days)	164,137

Short Selling Information

The latest short interest is 174,670, so 1.38% of the outstanding shares have been sold short.

Short Interest	174,670
Short Previous Month	188,538
Short % of Shares Out	1.38%
Short % of Float	1.81%
Short Ratio (days to cover)	0.70

Income Statement

In the last 12 months, HOOKIPA Pharma had revenue of $9.35 million and -$73.31 million in losses. Loss per share was -$5.85.

Revenue	9.35M
Gross Profit	-50.47M
Operating Income	-74.90M
Pretax Income	-48.43M
Net Income	-73.31M
EBITDA	-72.40M
EBIT	-74.90M
Loss Per Share	-$5.85

Full Income Statement

Balance Sheet

The company has $40.28 million in cash and $596,000 in debt, giving a net cash position of $39.68 million or $3.13 per share.

Cash & Cash Equivalents	40.28M
Total Debt	596,000
Net Cash	39.68M
Net Cash Per Share	$3.13
Equity (Book Value)	34.08M
Book Value Per Share	2.71
Working Capital	43.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.77 million and capital expenditures -$98,000, giving a free cash flow of -$52.87 million.

Operating Cash Flow	-52.77M
Capital Expenditures	-98,000
Free Cash Flow	-52.87M
FCF Per Share	-$4.17

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-801.02%
Pretax Margin	-785.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HOOKIPA Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.01%
Shareholder Yield	-16.01%
Earnings Yield	-390.87%
FCF Yield	-281.86%

Analyst Forecast

The average price target for HOOKIPA Pharma is $10.67, which is 651.41% higher than the current price. The consensus rating is "Buy".

Price Target	$10.67
Price Target Difference	651.41%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-12.45%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 10, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 10, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

HOOKIPA Pharma has an Altman Z-Score of -11.57 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.57
Piotroski F-Score	1